RA
BHC icon

Rise Advisors’s Bausch Health BHC Stock Holding History

Rise Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed -$408 – 1128
2024
Q3 		$408 Sell
50
-20
-29% -$132 ﹤0.01% 1198
2024
Q2 		$488 Hold
70
– – ﹤0.01% 1193
2024
Q1 		$743 Hold
70
– – ﹤0.01% 1199
2023
Q4 		$561 Hold
70
– – ﹤0.01% 558
2023
Q3 		$575 Hold
70
– – ﹤0.01% 571
2023
Q2 		$560 Hold
70
– – ﹤0.01% 613
2023
Q1 		$567 Hold
70
– – ﹤0.01% 728
2022
Q4 		$440 Hold
70
– – ﹤0.01% 718
2022
Q3 		$0 Hold
70
– – ﹤0.01% 707
2022
Q2 		$1K Hold
70
– – ﹤0.01% 609
2022
Q1 		$2K Hold
70
– – ﹤0.01% 520
2021
Q4 		$1.93K Buy
+70
New +$1.87K ﹤0.01% 537

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return

Rise Advisors's BHC Position: Q4 2024 in Review

Rise Advisors sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 50 shares — an estimated $408 sold.

Rise Advisors first reported a position in BHC in Q4 2021 and held it in 12 quarters. The position peaked at $2K in Q1 2022. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

  • Rise Advisors reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
  • Rise Advisors sold 50 Bausch Health shares in Q4 2024, an estimated $408.
  • Rise Advisors first reported a position in Bausch Health in Q4 2021 and held it in 12 quarters.
  • Rise Advisors's Bausch Health position peaked at $2K in Q1 2022.
  • 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on Rise Advisors's 13F filing for Q4 2024, filed 7 Jan 2025.